Literature DB >> 19738013

In vitro activity of a new quinoline derivative, ER-2, against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis.

Shilpakala Sainath Rao, Raghavachari Raghunathan, Ramesh Ekambaram, Malathi Raghunathan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19738013      PMCID： PMC2786322          DOI： 10.1128/AAC.00746-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  4 in total

Review 1.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

2.  Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC 17116.

Authors:  G E Kenny; F D Cartwright
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

3.  Synthesis and antibacterial property of quinolines with potent DNA gyrase activity.

Authors:  Ekambaram Ramesh; Rathna Durga R S Manian; Ragavachary Raghunathan; Shilpakala Sainath; Malathi Raghunathan
Journal:  Bioorg Med Chem       Date:  2008-12-03       Impact factor: 3.641

Review 4.  Structure-activity and structure-side-effect relationships for the quinolone antibacterials.

Authors:  J M Domagala
Journal:  J Antimicrob Chemother       Date:  1994-04       Impact factor: 5.790
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.